logo
Select company
Select metric
-379.27%Operating Cash Flow Margin
VS
Market
7
Sector
26
Industry
46
History
88
$ 6.71Close
$ 3 - $ 24.6 52-Week Range
Ticker Information

Ticker

GBIO

Company Name

GENERATION BIO CO

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

GENERATION BIO CO - Operating Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

GBIO - OCF % Historical data
DateNet Cash Flow - OperationsOperating Cash Flow MarginRevenues
6/30/2025$ -80.52M-379.27%$ 21.23M
3/31/2025$ -85.23M-347.07%$ 24.56M
12/31/2024$ -88.56M-445.22%$ 19.89M
9/30/2024$ -97.76M-526.08%$ 18.58M
6/30/2024$ -103.11M-782.65%$ 13.17M
3/31/2024$ -56.77M-569.76%$ 9.96M
12/31/2023$ -52.74M-893.38%$ 5.9M
9/30/2023$ -50.77M-1677.79%$ 3.03M
6/30/2023$ -46.35M-5267.16%$ 880K
3/31/2023$ -94.69M0%$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • GENERATION BIO CO's latest trailing twelve months (TTM) OCF % stands at 0%.
  • Over the past 5 years, GENERATION BIO CO's average OCF % has been -1209.82%.
  • The median OCF % for GENERATION BIO CO during this period was -569.76%
  • GENERATION BIO CO reached its highest OCF % over the past 5 years at -347.07%.
  • The lowest OCF % recorded by GENERATION BIO CO in the same timeframe -5267.16%

GENERATION BIO CO's OCF % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

OCF % Benchmarks
CompanyOCF %
XLO : XILIO THERAPEUTICS INC -88.85%BCAB : BIOATLA INC -475.66%CRIS : CURIS INC -267.05%PRPO : PRECIPIO INC 4.31%MRSN : MERSANA THERAPEUTICS INC -229.39%DYAI : DYADIC INTERNATIONAL INC -72%XFOR : X4 PHARMACEUTICALS INC -333.48%NEPH : NEPHROS INC 11.97%POCI : PRECISION OPTICS CORPORATION INC -18.58%NRXS : NEURAXIS INC -193.38%

Definition of Operating Cash Flow Margin

[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
CF - Operations / Revenues
(=) OCF %
OCF % for GENERATION BIO CO is calculated as follows: CF - Operations [ $ -70.14M ] / Revenues [ $ 0 ]
(=) OCF % [ 0% ]

GBIO - Operating Cash Flow Margin, Last 5 years

-5267.16%

Minimum

Jun 30, 2023

-347.07%

Maximum

Mar 31, 2025

-1209.82%

Average

-569.76%

Median

OCF % Benchmark Analysis

The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.31% with a standard deviation of 21.13%.
The following table provides additional summary stats:
OCF % in the Market:
filtered constituents3.25K
min-57.27%
max77.08%
average14.31%
median12.65%
std21.13%